Congenital alpha(2)-plasmin inhibitor deficiencies: a review

Br J Haematol. 2001 Jul;114(1):4-10. doi: 10.1046/j.1365-2141.2001.02845.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Aminocaproates / therapeutic use
  • Antifibrinolytic Agents / therapeutic use
  • Fibrinolysis
  • Hemorrhagic Disorders / drug therapy
  • Hemorrhagic Disorders / genetics*
  • Homozygote
  • Humans
  • Plasma
  • Tranexamic Acid / therapeutic use
  • alpha-2-Antiplasmin / chemistry
  • alpha-2-Antiplasmin / deficiency*

Substances

  • Aminocaproates
  • Antifibrinolytic Agents
  • alpha-2-Antiplasmin
  • Tranexamic Acid